{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T15:08:41Z","timestamp":1775833721658,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5KL2TR002015-06"],"award-info":[{"award-number":["5KL2TR002015-06"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.contraception.2024.110530","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:37:50Z","timestamp":1718811470000},"page":"110530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy &lt;12 weeks gestation"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6570-9606","authenticated-orcid":false,"given":"Sarah","family":"Horvath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Calo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark H.","family":"Yazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2024.110530_bib1","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1097\/AOG.0000000000002232","article-title":"Prevention of RhD alloimmunization. ACOG Practice Bulletin, Number 181","volume":"130","author":"Obstetricians ACo, Gynecologists","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.contraception.2024.110530_bib2","first-page":"457","article-title":"ACOG Practice Bulletin No. 75: management of alloimmunization during pregnancy","volume":"108","author":"Obstetricians ACoGynecologists","year":"2006","journal-title":"Obstet\u00a0Gynecol"},{"issue":"12","key":"10.1016\/j.contraception.2024.110530_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.2023.16953","article-title":"Induced abortion and the risk of Rh sensitization","volume":"330","author":"Horvath","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.contraception.2024.110530_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2020.02.011","article-title":"The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization","volume":"102","author":"Horvath","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110530_bib5","article-title":"Can we safely stop testing for Rh status and immunizing Rh-negative women having early abortions? A comparison of Rh alloimmunization in Canada and the Netherlands","volume":"1","author":"Wiebe","year":"2019","journal-title":"Contracept\u00a0X"},{"issue":"Suppl 18","key":"10.1016\/j.contraception.2024.110530_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1471-0528.1998.tb10286.x","article-title":"The scientific basis of antenatal prophylaxis","volume":"105","author":"Urbaniak","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.contraception.2024.110530_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.contraception.2019.03.051","article-title":"\u201cProvoked\u201d feto-maternal hemorrhage may represent insensible cell exchange in pregnancies from 6 to 22 weeks gestational age","volume":"100","author":"Hollenbach","year":"2019","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110530_bib8","series-title":"Abortion care guideline","author":"WHO","year":"2022"},{"key":"10.1016\/j.contraception.2024.110530_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2022.07.002","article-title":"Society of Family Planning committee consensus on Rh testing in early pregnancy","volume":"114","author":"Horvath","year":"2022","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2024.110530_bib10","unstructured":"(RCOG) RCoOaG. Best practice in abortion care; 2022. Accessed March 25, 2024. https:\/\/www.rcog.org.uk\/media\/geify5bx\/abortion-care-best-practice-paper-april-2022.pdf."},{"issue":"5","key":"10.1016\/j.contraception.2024.110530_bib11","first-page":"B2","article-title":"Society for Maternal-Fetal Medicine Statement: RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation","volume":"230","author":"Prabhu","year":"2024","journal-title":"Am\u00a0J\u00a0Obstet\u00a0Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2024.110530_bib12","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"Committee on Practice B-G. ACOG Practice Bulletin No. 200: early pregnancy loss","volume":"132","author":"American College of Obstetricians and Gynecologists","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110530_bib13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Committee on Practice Bulletins-Gynecology SoFP. Medication abortion up to 70 days of gestation: ACOG Practice Bulletin, Number 225","volume":"136","author":"American College of Obstetricians and\u00a0Gynecologists","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2024.110530_bib14","unstructured":"ACOG. Rho(D) Immune Globulin Shortages ACOG website2024 [cited 2024 March].\u00a0Accessed March 25, 2024. https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2024\/03\/rhod-immune-globulin-shortages?utm_source=higher-logic&utm_medium=email&utm_content=Mar-15&utm_campaign=acog2024-rounds."},{"issue":"7","key":"10.1016\/j.contraception.2024.110530_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235807","article-title":"Hemolytic disease of the fetus and newborn due to Rh (D) incompatibility: a preventable disease that still produces significant morbidity and mortality in children","volume":"15","author":"Pegoraro","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2024.110530_bib16","series-title":"Ultra-filtered PLUS MICRhoGAM ultra-filtered PLUS (Rho(D) immune globulin (Human)) [package insert]","author":"RhoGAM","year":"2022"},{"key":"10.1016\/j.contraception.2024.110530_bib17","unstructured":"WinRho \u00ae SDF. Rho(D) immune globulin intravenous (Human)\u00a0[package insert]. Roswell, GA:\u00a0Saol Therapeutics Inc.; 2019."},{"key":"10.1016\/j.contraception.2024.110530_bib18","unstructured":"RHOPHYLAC. RhO(D) immune globulin intravenous (Human)\u00a0[package insert]. Kankakee, IL: CSL Behring LLC; 2020."},{"key":"10.1016\/j.contraception.2024.110530_bib19","first-page":"143","article-title":"When should decision-analytic modeling be used in the economic evaluation of health care?","volume":"4","author":"Siebert","year":"2003","journal-title":"Springer"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2024.110530_bib20","article-title":"Another piece of the hemolytic disease of the fetus and newborn puzzle after RhD-positive transfusion in trauma resuscitation: the proportion of pregnant women who produce high titer anti-D","volume":"9","author":"Yazer","year":"2024","journal-title":"Trauma Surg\u00a0Acute Care Open"},{"key":"10.1016\/j.contraception.2024.110530_bib21","series-title":"Pregnancy rates for US women continue to drop: US Department of Health and Human Services","author":"Curtin","year":"2013"},{"issue":"9","key":"10.1016\/j.contraception.2024.110530_bib22","first-page":"926","article-title":"The significance of extrachorionic membrane separation in threatened miscarriage","volume":"103","author":"Farrell","year":"1996","journal-title":"Br\u00a0J\u00a0Obstet\u00a0Gynaecol"},{"issue":"9","key":"10.1016\/j.contraception.2024.110530_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7009a1","article-title":"Abortion surveillance - United States, 2019","volume":"70","author":"Kortsmit","year":"2021","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"10.1016\/j.contraception.2024.110530_bib24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajog.2003.09.023","article-title":"Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study","volume":"190","author":"Weiss","year":"2004","journal-title":"Am J\u00a0Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.contraception.2024.110530_bib25","first-page":"128","article-title":"Abortion incidence and service availability in the United States, 2020","volume":"54","author":"Jones","year":"2022","journal-title":"Perspect\u00a0Sex\u00a0Reproduct\u00a0Health"},{"issue":"6","key":"10.1016\/j.contraception.2024.110530_bib26","first-page":"1285","article-title":"Patient experiences with miscarriage management in the emergency and ambulatory settings","volume":"134","author":"Miller","year":"2019","journal-title":"Obstet\u00a0Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2024.110530_bib27","first-page":"219","article-title":"Use of Rh immune globulin in first-trimester abortion and miscarriage","volume":"141","author":"Gilmore","year":"2023","journal-title":"Obstet\u00a0Gynecol"},{"issue":"5","key":"10.1016\/j.contraception.2024.110530_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/trf.16826","article-title":"Cost\u2010effectiveness of noninvasive fetal RhD blood group genotyping in nonalloimmunized and alloimmunized pregnancies","volume":"62","author":"Gajic\u2010Veljanoski","year":"2022","journal-title":"Transfusion"},{"key":"10.1016\/j.contraception.2024.110530_bib29","first-page":"1","article-title":"Fertility of men and women aged 15-49 in the United States: National Survey of Family Growth, 2015-2019","volume":"179","author":"Martinez","year":"2023","journal-title":"Natl Health Stat\u00a0Rep"},{"issue":"12","key":"10.1016\/j.contraception.2024.110530_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pd.5355","article-title":"The near disappearance of fetal hydrops in relation to current state\u2010of\u2010the\u2010art management of red cell alloimmunization","volume":"38","author":"Zwiers","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.contraception.2024.110530_bib31","doi-asserted-by":"crossref","unstructured":"Rossen LM, Hamilton BE, Abma JC, Gregory EC, Beresovsky V, Resendez A, et al. Updated methodology to estimate overall and unintended pregnancy rates in the United States; 2023. Accessed March 25, 2024. https:\/\/stacks.cdc.gov\/view\/cdc\/124395.","DOI":"10.15620\/cdc:124395"},{"issue":"9","key":"10.1016\/j.contraception.2024.110530_bib32","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMsa1506575","article-title":"Declines in unintended pregnancy in the United States, 2008\u20132011","volume":"374","author":"Finer","year":"2016","journal-title":"N\u00a0Engl J\u00a0Med"},{"issue":"4","key":"10.1016\/j.contraception.2024.110530_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1377\/hlthaff.2021.01528","article-title":"Trends in self-pay charges and insurance acceptance for abortion in the United States, 2017\u201320: study examines trends in self-pay charges for abortion in the United States, 2017-20","volume":"41","author":"Upadhyay","year":"2022","journal-title":"Health Aff"},{"issue":"3","key":"10.1016\/j.contraception.2024.110530_bib34","article-title":"Early pregnancy loss management in the emergency department vs outpatient setting","volume":"6","author":"Benson","year":"2023","journal-title":"JAMA Netw\u00a0Open"},{"key":"10.1016\/j.contraception.2024.110530_bib35","series-title":"Mollison's blood transfusion in clinical medicine","author":"Klein","year":"2014"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424002178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782424002178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T15:38:51Z","timestamp":1728315531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782424002178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"alternative-id":["S0010782424002178"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110530","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2024.110530","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110530"}}